| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
9 companies
Opaleye Management Inc. is a 10% Owner at CDXS with holdings across 9 companies. Recent SEC Form 4 filings include 5 buys and 18 sells.
Estimated insider holdings value: $139.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 28, 2024 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 64,568 | $2.21 | $142,502.70 | -1.4% | -12.0% | +38.5% | |
| Jun 25, 2024 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 12,725 | $2.26 | $28,734.32 | -0.5% | -10.0% | +37.6% | |
| May 31, 2024 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 15,054 | $2.92 | $44,007.97 | -6.3% | -28.1% | +8.2% | |
| May 22, 2024 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 42,800 | $3.05 | $130,434.45 | -0.9% | -26.4% | +6.0% | |
| May 17, 2024 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 70,885 | $3.25 | $230,325.63 | -1.4% | -33.7% | +3.2% | |
| May 10, 2024 | TARA Protara Therapeutics, Inc. | 10% Owner | Sell | 182,300 | $3.11 | $566,950.60 | -3.6% | -36.7% | +8.0% | |
| Apr 25, 2024 | HROW Harrow, Inc. | 10% Owner | Buy | 20,000 | $9.97 | $199,400.00 | +0.5% | +138.7% | +155.5% | |
| Apr 24, 2024 | HROW Harrow, Inc. | 10% Owner | Buy | 20,000 | $10.23 | $204,640.10 | +0.3% | +138.4% | +144.1% | |
| Apr 19, 2024 | HROW Harrow, Inc. | 10% Owner | Buy | 29,400 | $10.56 | $310,390.50 | +0.8% | +135.3% | +122.4% | |
| Mar 28, 2024 | HROW Harrow, Inc. | 10% Owner | Buy | 50,000 | $12.82 | $641,000.00 | +1.4% | +61.3% | +98.1% |